Sarah McCabe
Papers
1
Total Citations
13
H-Index
1
About
Dr. Sarah McCabe is a leading researcher in precision public health, with a focus on integrating genomic screening into routine population health systems. Her major contributions center on demonstrating the feasibility and clinical utility of large-scale, unselected genetic screening for actionable hereditary conditions. In her landmark 2023 study, "Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon," Dr. McCabe and her team screened thousands of individuals, revealing that a significant percentage carry previously undetected pathogenic variants for hereditary breast and ovarian cancer, Lynch syndrome, and familial hypercholesterolemia. This work, which has already garnered 13 citations, provides critical evidence that population-based genomic screening can identify at-risk individuals who would otherwise be missed by family history-based approaches. Her research directly informs public health policy and clinical guidelines, advocating for a shift from reactive to preventive medicine. Dr. McCabe's work is notable for its real-world impact, bridging the gap between genomic discovery and community health, and establishing a model for scalable, equitable screening programs that can reduce the burden of inherited disease.
Research Focus
Key Achievements
Top Papers
- 1